Trade Mark Journal No.2026/030 24 July 2026

UK00004394787 29 May 2026 (5,42)

Image for mark UK00004394787 A ATRIUM THERAPEUTICS
International priority date claimed: 13 February 2026 (United States of America) (99652424)
Class 5
Biological, medicinal and pharmaceutical preparations, namely, oligonucleotide- based therapeutics for the treatment of cardiovascular, cardiomyopathies, and heart muscle related diseases and disorders.
Class 42
Providing medical and scientific research information in the fields of pharmaceuticals and biotechnology.

Atrium Therapeutics, Inc.

Representative: Abion UK Limited